Extrait

This study will characterize the safety, tolerability, biological activity, and pharmacokinetics of LBH589 in Japanese patients with advanced solid tumors whose disease has progressed despite standard therapies, or for whom no standard therapy exists.

Critère d'inclusion

• Cancer,Advanced Solid Tumor

Liens

• ictrp
• nct